TenoTimes LogoTenoTimes Logo
HomeAutomobilesBusinessCelebritiesElectronicsEntertainmentLocalPoliticsSportsTechnologyWealthWorld
TenoTimes Logo
About UsContactPrivacy PolicyTerms of Service
X

© 2026 TenoTimes. All Rights Reserved.

    Breaking News
    NDA Registers Landmark Victory in Bihar Election 2025‘King’: Shah Rukh Khan’s ₹200 Crore Power Move to Redefine Bollywood ActionCyclone 'Montha' Slams India’s East Coast, IMD Warns of Heavy Rain and Strong WindsHonda CB500X 2025: Adventure and Reliability for Global RidersKTM 890 Duke R 2025: Lightweight Performance for Global MarketsTesla’s Global Delivery Surge: Strategies Behind the Record Q3 2025 PerformanceVolkswagen’s EV Expansion: Strategic Move to Dominate Global Electric Vehicle MarketKabul Says “Retaliatory Operations” Secured Border, Claims Dozens of Pakistani LossesPakistan Condemns “Unprovoked Afghan Fire” as Border Crossings CloseNDA Registers Landmark Victory in Bihar Election 2025‘King’: Shah Rukh Khan’s ₹200 Crore Power Move to Redefine Bollywood ActionCyclone 'Montha' Slams India’s East Coast, IMD Warns of Heavy Rain and Strong WindsHonda CB500X 2025: Adventure and Reliability for Global RidersKTM 890 Duke R 2025: Lightweight Performance for Global MarketsTesla’s Global Delivery Surge: Strategies Behind the Record Q3 2025 PerformanceVolkswagen’s EV Expansion: Strategic Move to Dominate Global Electric Vehicle MarketKabul Says “Retaliatory Operations” Secured Border, Claims Dozens of Pakistani LossesPakistan Condemns “Unprovoked Afghan Fire” as Border Crossings Close

    Articles tagged with

    #IndianPharma
    Rubicon Research IPO: Specialty Pharma Player Targets ₹1,085 Cr Issue

    Rubicon Research IPO: Specialty Pharma Player Targets ₹1,085 Cr Issue

    Mumbai-based Rubicon Research eyes a strong market debut with its ₹1,085 crore IPO, backed by U.S. approvals and growing profitability.

    Ad Placeholder (Slot: 8763699451)